Centre Orthopédique Santy, Lyon, France.
Hôpital Privé Jean Mermoz, Ramsay-Générale de Santé, Lyon, France.
Am J Sports Med. 2022 Feb;50(2):395-403. doi: 10.1177/03635465211061123. Epub 2021 Dec 13.
Additional lateral extra-articular tenodesis (LET) has recently been correlated with improved clinical outcomes and reduced failure rates in revision anterior cruciate ligament (ACL) reconstruction (ACLR). However, no data are available on clinical outcomes and reoperation after revision ACLR using different LET procedures.
To compare the clinical outcomes of ACL + anterolateral ligament (ALL) reconstruction using hamstring tendon graft (HT-ALL) and a bone-patellar tendon-bone (BPTB) graft + modified Lemaire tenodesis procedure (BPTB-Lemaire) in the setting of revision ACLR and to determine whether ALL reconstruction is associated with an increased rate of adverse outcomes when compared with a modified Lemaire tenodesis procedure.
Cohort study; Level of evidence, 3.
Descriptive data and clinical outcomes were prospectively collected from patients who underwent revision ACLR with LET between 2009 and 2018 with a minimum follow-up of 2 years. Patients with an HT autograft combined with ALL reconstruction (HT-ALL group) were matched in a 1:1 propensity ratio to patients with a BPTB autograft combined with a modified Lemaire LET procedure (BPTB-Lemaire group). The evaluated parameters included complications and reoperations; knee laxity tests; return to sports; and various scores, including the Lysholm knee score, Tegner activity scale, Anterior Cruciate Ligament Return to Sport After Injury scale, Marx activity rating scale, International Knee Documentation Committee subjective knee evaluation form, and Knee injury and Osteoarthritis Outcome Score.
In total, 36 matched pairs were included in the analysis. The mean follow-up durations for the BPTB-Lemaire and HT-ALL groups were 56 ± 35 and 57 ± 23 months, respectively ( = .91). No significant differences were found in graft rupture rate (HT-ALL, 0%; BPTB-Lemaire, 11.1%; = .13) or reoperations (HT-ALL, 8.3%; BPTB-Lemaire, 22.2%; = .23). No specific complications with regard to LET were noted in either group. Additionally, there were no significant differences in knee laxity parameters, return to sports, or clinical scores between the groups at the final follow-up, except for the Tegner activity scale score (HT-ALL, 6.4; BPTB-Lemaire, 7.3; = .03). HT-ALL was associated with a shorter surgical time (41.4 vs 59.8 minutes; < .0001).
HT-ALL was at least equivalent, in terms of clinical outcomes, to the more commonly performed procedure, BPTB-Lemaire. Performing ALL reconstruction in the setting of revision ACLR is therefore safe and effective.
最近的研究表明,在初次前交叉韧带(ACL)重建(ACLR)中进行额外的外侧关节外腱固定(LET)与改善临床结果和降低失败率有关。然而,在初次 ACLR 中使用不同 LET 手术的情况下,关于临床结果和再次手术的数据尚未见报道。
比较在初次 ACLR 中使用腘绳肌腱移植物(HT-ALL)进行 ACL+前外侧韧带(ALL)重建和使用骨-髌腱-骨(BPTB)移植物+改良 Lemaire 腱固定术(BPTB-Lemaire)进行 ACL+ALL 重建的临床结果,并确定 ALL 重建与改良 Lemaire 腱固定术相比是否会增加不良结果的发生率。
队列研究;证据等级,3 级。
前瞻性收集 2009 年至 2018 年期间接受 LET 初次 ACLR 的患者的描述性数据和临床结果,随访时间至少 2 年。使用 1:1 倾向评分匹配法将使用 HT 自体移植物联合 ALL 重建(HT-ALL 组)的患者与使用 BPTB 自体移植物联合改良 Lemaire LET 手术的患者进行匹配(BPTB-Lemaire 组)。评估的参数包括并发症和再次手术;膝关节松弛度检查;重返运动;以及各种评分,包括 Lysholm 膝关节评分、Tegner 活动量表、前交叉韧带损伤后重返运动量表、Marx 活动评级量表、国际膝关节文献委员会膝关节主观评估表和膝关节损伤和骨关节炎结果评分。
共纳入 36 对匹配的患者。BPTB-Lemaire 组和 HT-ALL 组的平均随访时间分别为 56 ± 35 个月和 57 ± 23 个月( =.91)。两组的移植物破裂率(HT-ALL,0%;BPTB-Lemaire,11.1%; =.13)或再次手术率(HT-ALL,8.3%;BPTB-Lemaire,22.2%; =.23)均无显著差异。两组均未出现 LET 相关的特定并发症。此外,除 Tegner 活动量表评分外(HT-ALL,6.4;BPTB-Lemaire,7.3; =.03),两组在最终随访时的膝关节松弛度参数、重返运动和临床评分均无显著差异。HT-ALL 的手术时间更短(41.4 分钟 vs 59.8 分钟; <.0001)。
在临床结果方面,HT-ALL 与更常用的 BPTB-Lemaire 手术至少具有同等效果。因此,在初次 ACLR 中进行 ALL 重建是安全有效的。